there is so much they can do with product innovation and new markets. certainly China IMF is great and its a strategically important market but you can return to double digit growth in sales and profit with elderly nutrition and other product categories.
the US is the next big pillar for the company. i want to see the 800m deployed for growth and capital management like a recurring buy back until they find the next big thing ie US or elderly nutrition as an example
there is so much they can do with product innovation and new...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$8.27 |
Change
0.090(1.10%) |
Mkt cap ! $5.987B | |||
| Open | High | Low | Value | Volume |
| $8.18 | $8.33 | $8.16 | $25.84M | 3.148M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3616 | $8.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.27 | 12097 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |